Tikosyn manufacturing issue resolved
This article was originally published in The Gold Sheet
Executive Summary
Pfizer Feb. 1 said it had resolved an outage of its anti-arrhythmia drug Tikosyn (dofetilide) that resulted from "an unforeseen manufacturing issue." Because Tikosyn is drop-shipped and has no inventory in trade, the supply ran out before Pfizer could solve the problem